Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Search
Generic filters

Why breakthrough human trials of Actiphage are good news for farmers

The findings are a real breakthrough for animal diagnosis as it provides clinical evidence that detection of low levels of mycobacteria in the blood is an indication that the animal is infected and has the potential to develop disease.
  • May 12, 2022
  • Human health, Johne's Disease
cow

Johne’s Disease develops slowly, so it may be several years after a cow has been infected that it begins to show symptoms of disease. However, symptoms can also be triggered by stress such as calving, when the cow’s immune response is suppressed. Johne’s is a ticking time bomb in the herd.

Johne’s Disease, along with bovine tuberculosis (bTB) and human tuberculosis, is caused by a strain of mycobacteria, a clever bacteria that can hide in the body.

PBD Biotech is investigating the application of its blood test, Actiphage®, to detecting mycobacterial diseases in both humans and animals and recent findings from a human trial have important implications for animal diagnostics.

TB detection priority for WHO

A quarter of the human population have latent TB, meaning they are infected but show no symptoms. A small number of those will progress to full infection, which is called incipient TB. If it were possible to easily identify people with incipient TB, these individuals could be targeted for preventative treatment, a top priority for the WHO.

Now, human trials of Actiphage have shown that there is a link between the presence of mycobacterial cells in the blood and incipient TB in humans. The study used imaging to provide clinical evidence of incipient TB, a technique that would be too costly for widespread use with humans or for animals.

Actiphage diagnostic for human TB

Evidence from this study shows that there is potential to use Actiphage as a blood test for screening a high-risk population for incipient TB, and it also offers an alternative to the current sputum test that is difficult for children and the vulnerable to use. The use of Actiphage as a diagnostic for human TB is currently being explored in a project in Zambia.

Breakthrough for animal diagnostics

The research is also a real breakthrough for animal diagnosis as it provides clinical evidence that detection of low levels of mycobacteria in the blood is an indication that the animal is infected and has the potential to develop disease. Conversely, if no mycobacteria is found then the cow is clear.

This provides further verification that Actiphage can provide a rapid yes/no test for Johne’s Disease, also known as MAP. Additionally, as the test directly detects the bacteria responsible rather than the animal’s immune response, it is more likely to give results on which actions can be based.

PBD Biotech has recently launched a Johne’s Disease testing service based on Actiphage. If you would like to discuss the service, which can test either blood or bulk milk, then do get in contact.

Share:
Share on facebook
Share on twitter
Share on linkedin

Related posts

Loading...
ECCMID

Actiphage® TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022
A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live bacteria can be detected in the blood of people with incipient TB infection.
ECCMID

Actiphage® TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022
A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live...
Johnes Disease testing service

Is there Johne’s Disease in the herd? PBD’s new testing service provides yes/no answer

April 7, 2022
A new rapid testing service from PBD Biotech will enable farmers to find out in days if a bulk milk or blood sample contains MAP, the bacteria that causes Johne's Disease an economically devastating disease.
Johnes Disease testing service

Is there Johne’s Disease in the herd? PBD’s new testing service provides yes/no answer

April 7, 2022
A new rapid testing service from PBD Biotech will enable farmers to find out in days if a bulk milk...
Johnes Disease testing service

7th April 2022, Stoneleigh Park, CV8 2LH

Dairy-Tech 2022 PBD Biotech to launch new Johne’s Disease testing service

April 1, 2022
PBD Biotech to launch at Dairy-Tech, a new rapid test that will enable farmers to find out in days if a bulk milk or blood sample contains MAP, the cause of Johne's Disease
Johnes Disease testing service

7th April 2022, Stoneleigh Park, CV8 2LH

Dairy-Tech 2022 PBD Biotech to launch new Johne’s Disease testing service

April 1, 2022
PBD Biotech to launch at Dairy-Tech, a new rapid test that will enable farmers to find out in days if...
rapid TB test World TB Day - Zambart image

Could Actiphage provide rapid TB test in sub-Saharan Africa?

March 23, 2022
Sub-Saharan Africa is devastated by TB disease. Zambia, has a high TB/HIV burden – 59,000 people developed TB in 2020 and 15,000 died. There is a critical need for a non-sputum based rapid test for diagnosing TB disease.
rapid TB test World TB Day - Zambart image

Could Actiphage provide rapid TB test in sub-Saharan Africa?

March 23, 2022
Sub-Saharan Africa is devastated by TB disease. Zambia, has a high TB/HIV burden – 59,000 people developed TB in 2020...
1 2 3 Next »

developers of phage-based diagnostics

Contact Us

PBD Biotech Ltd
Link House, Elm Farm Park,
Great Green, Thurston,
Suffolk IP31 3SH,
United Kingdom

Registered Company Address
Ingenuity Centre,
University of Nottingham,
Innovation Park, Triumph Rd,
Nottingham NG7 2TU,
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

Health Protection Scotland has launched a consultation on bovine tuberculosis diagnostic testing - but only the skin test? Why not the use of a blood test, pre-movement to keep Scotland OTF status by detecting early infection? @P_H_S_Official @BritishVets

Read More
PBD Biotech

Johne's Disease is a ticking time bomb in the dairy herd, now Actiphage provides a pre-breeding blood test to stop its transmission. We explain the relevance of new research that proves the link between mycobacteria in the blood and the development of TB

Read More
PBD Biotech

Delighted to be taking our Actiphage tuberculosis blood test to Zambia, in a collaborative project with @ZambartResearch, @LSHTM, @LeicResearch The aim is to test its sensitivity in a real world setting. #Tuberculosis #EndTB #InvestToEndTB

Read More